MYDECINE INNOVATIONS GROUP INC.MYDECINE INNOVATIONS GROUP INC.MYDECINE INNOVATIONS GROUP INC.

MYDECINE INNOVATIONS GROUP INC.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪264.57 K‬CAD
−0.285CAD
‪−20.95 M‬CAD
0.00CAD
‪25.73 M‬
Beta (1Y)
4.71

About MYDECINE INNOVATIONS GROUP INC.


CEO
David Joshua Bartch
Headquarters
Vancouver
Founded
2013
FIGI
BBG0086KMT58
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MYCO is 0.010 CAD — it has increased by 100.00% in the past 24 hours. Watch MYDECINE INNOVATIONS GROUP INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange MYDECINE INNOVATIONS GROUP INC. stocks are traded under the ticker MYCO.
MYCO reached its all-time high on Aug 27, 2018 with the price of 348.750 CAD, and its all-time low was 0.005 CAD and was reached on Oct 17, 2024. View more price dynamics on MYCO chart.
See other stocks reaching their highest and lowest prices.
MYCO stock is 50.00% volatile and has beta coefficient of 4.71. Track MYDECINE INNOVATIONS GROUP INC. stock price on the chart and check out the list of the most volatile stocks — is MYDECINE INNOVATIONS GROUP INC. there?
Yes, you can track MYDECINE INNOVATIONS GROUP INC. financials in yearly and quarterly reports right on TradingView.
MYDECINE INNOVATIONS GROUP INC. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
MYCO net income for the last quarter is ‪−1.99 M‬ CAD, while the quarter before that showed ‪−2.67 M‬ CAD of net income which accounts for 25.40% change. Track more MYDECINE INNOVATIONS GROUP INC. financial stats to get the full picture.
No, MYCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MYCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYDECINE INNOVATIONS GROUP INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYDECINE INNOVATIONS GROUP INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYDECINE INNOVATIONS GROUP INC. stock shows the sell signal. See more of MYDECINE INNOVATIONS GROUP INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.